NeuroSense Therapeutics Ltd. Cost, Depreciation, Amortization and Depletion
NeuroSense Therapeutics Ltd. (NRSN) reported Cost, Depreciation, Amortization and Depletion of $29.00 thousand for the 12-month period ending 2023-12-31, per its 6-K filed 2024-06-17.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CostDepreciationAmortizationAndDepletion · last filed 2024-06-17
| Period end | Cost, Depreciation, Amortization and Depletion 12 month |
|---|---|
| 2023-12-31 | $29.00K 6-K · filed 2024-06-17 |
| 2022-12-31 | $70.00K 6-K · filed 2024-06-17 |